| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 07/25/2002 | CA2435260A1 Receptors and membrane-associated proteins |
| 07/25/2002 | CA2435037A1 Bifunctional fusion proteins with glucocerebrosidase activity |
| 07/25/2002 | CA2433354A1 Affinity selection-based screening of hydrophobic proteins |
| 07/25/2002 | CA2432730A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/25/2002 | CA2331676A1 Method for the expression, purification, and structure recovery and handling of hydrophobic proteins, polypeptides or peptides |
| 07/24/2002 | EP1224471A2 Dpi-6, a therapeutic biomarker in neurological disorders |
| 07/24/2002 | EP1224301A2 Methods and compositions for targeting a cell |
| 07/24/2002 | EP1224222A2 Chemokine receptor |
| 07/24/2002 | EP1224213A2 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 07/24/2002 | EP1223964A1 April receptor (bcma) and uses thereof |
| 07/24/2002 | EP1223958A2 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 07/24/2002 | EP0938679B1 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay |
| 07/23/2002 | US6423513 Polynucleotide encoding proprotein comprising cell recognition domain binding to exterior surface of targeted cell, domain effecting translocation to cell cytosol upon proteolytic cleavage, cytotoxicity domain, endoplasmic reticulum retention |
| 07/23/2002 | US6423316 Anticoagulant fusion protein anchored to cell membrane |
| 07/23/2002 | CA2168440C Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/23/2002 | CA2072642C Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
| 07/18/2002 | WO2002056022A2 Diagnostics, drug screening and treatment for cancer |
| 07/18/2002 | WO2002055992A2 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof |
| 07/18/2002 | WO2002055725A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 07/18/2002 | WO2002055555A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | WO2002055539A1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |
| 07/18/2002 | WO2002055098A2 Latency associated peptide for providing latency to pharmaceutically active proteins |
| 07/18/2002 | WO2002028414B1 Compositions and methods for wt1 specific immunotherapy |
| 07/18/2002 | WO2002006311A3 Olfactory g-protein coupled receptor |
| 07/18/2002 | WO2002004522A3 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2002002143A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 07/18/2002 | WO2001094607A3 High level production of p-hydroxybenzoic acid in green plants |
| 07/18/2002 | WO2001085798A3 Human monoclonal antibodies to dendritic cells |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001083525A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 07/18/2002 | WO2001081408A3 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 07/18/2002 | WO2001081377A3 Integrin/adhesion antagonists |
| 07/18/2002 | WO2001079468A3 Drug metabolizing enzymes |
| 07/18/2002 | WO2001068705A3 Il-17 receptor like molecules and uses thereof |
| 07/18/2002 | WO2001051520A9 Nogo receptor-mediated blockade of axonal growth |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020094954 Nucleic acids comprising the neuregulin-1-associated gene 1 (NRG1AG1) |
| 07/18/2002 | US20020094551 T2R taste receptors and genes ecncoding same |
| 07/18/2002 | US20020094340 Chlamydia antigens and corresponding dna thereof |
| 07/18/2002 | DE10059631A1 T-Zellepitope des Papillomavirus L1-und E7-Proteins und ihre Verwendung in Diagnostik und Therapie T cell epitopes of the papillomavirus L1 and E7 protein and their use in diagnostics and therapy |
| 07/18/2002 | CA2434672A1 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | CA2433689A1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 07/18/2002 | CA2432883A1 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 07/18/2002 | CA2430060A1 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |
| 07/18/2002 | CA2428497A1 Targeted modification of intracellular compounds |
| 07/17/2002 | EP1223220A1 Genes coding for hydroxynitrile lyase, recombinant proteins with hydroxynitrile lyase activity and their use |
| 07/17/2002 | EP1222289A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222212A1 Il13 mutants |
| 07/17/2002 | EP1222207A1 C-peptide for the improved production of insulin and insulin analogues |
| 07/17/2002 | EP1222206A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 07/17/2002 | EP1222200A1 Vaccine |
| 07/17/2002 | EP0870037B1 Methods and compositions for synthesis of oligosaccharides using mutant glycosidase enzymes |
| 07/17/2002 | EP0804219B1 Inhibin compositions and methods of use thereof |
| 07/17/2002 | CN1359424A Pesticidal fusions |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420134 Vaccines for nontypable haemophilus influenzae |
| 07/16/2002 | US6419921 DNA-constructs of blood clotting factors and P-Selectin |
| 07/16/2002 | CA2366135A1 New genes containing a dna sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof |
| 07/16/2002 | CA2239360C G-csf analog compositions and methods |
| 07/16/2002 | CA2095926C Anti-human milk fat globule humanised antibodies |
| 07/11/2002 | WO2002054065A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | WO2002053761A2 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |
| 07/11/2002 | WO2002053182A1 Chimeric t helper-b cell peptide vaccine for japanese encephalitis virus |
| 07/11/2002 | WO2002027315A3 Compounds with a branched linker |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2001030392A3 Delivery of proteins across polar epithelial cell layers |
| 07/11/2002 | US20020091246 Dendritic cell co-stimulatory molecules |
| 07/11/2002 | US20020091079 An empty sc-MHC class II molecule comprising a peptide binding groove and a class II beta 2 chain comprising at least one amino acid substitution or deletion; immunosuppressants |
| 07/11/2002 | US20020090610 Polypeptide for use in the detection, diagnosis, prevention and treatment of vial disease |
| 07/11/2002 | US20020090379 Poviding self-protein analog by molecular biological means by substitution of one or more peptide fragments of self-protein by corresponding number of peptides known to contain immunodominant foreign T-cell epitopes |
| 07/11/2002 | CA2467434A1 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | CA2433782A1 Proteins and nucleic acids encoding same |
| 07/11/2002 | CA2432426A1 Recombinant protective protein from streptococcus pneumoniae |
| 07/10/2002 | EP1221488A1 Stress proteins and uses therefor |
| 07/10/2002 | EP1220933A1 Purification of recombinant proteins fused to multiple epitopes |
| 07/10/2002 | EP1220925A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220915A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 07/10/2002 | EP1220864A1 Transgenically produced fusion proteins |
| 07/10/2002 | EP0931162A4 Production of a multimeric protein by cell fusion method |
| 07/10/2002 | EP0517805B1 Identification and expression of insect steroid receptor dna sequences |
| 07/10/2002 | CN1358198A Chimeric polypeptides, method for production and uses thereof |
| 07/09/2002 | US6417336 Antibody against cleavage product or vimentin |
| 07/09/2002 | US6416950 Linking nucleic acid reverse transcription primer which is bound to peptide acceptor to rna, translating rna to produce protein product covalently bound to primer, reverse transcribing rna to produce dna-protein fusion |
| 07/04/2002 | WO2002052029A1 Process for producing recombinant protein and fused protein |
| 07/04/2002 | WO2002051871A2 Anti-cd28 antibody |
| 07/04/2002 | WO2002026988A9 Human drug metabolizing enzymes |
| 07/04/2002 | WO2002012274A3 Iapl-3 a protein inhibitor of apoptosis proteins |
| 07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
| 07/04/2002 | WO2001078768A3 Targeted vaccine delivery systems |
| 07/04/2002 | US20020086972 Adaptor protein FRS2 and related products and methods |